{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:38:56Z","timestamp":1789706336851,"version":"4.0.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T00:00:00Z","timestamp":1671494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T00:00:00Z","timestamp":1671494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2020-01058"],"award-info":[{"award-number":["2020-01058"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002848","name":"Comisi\u00f3n Nacional de Investigaci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract\n<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Approximately half of all women suffer from heartburn at some stage during pregnancy. The most effective treatment is proton pump inhibitors, but the safety of use during pregnancy cannot be guaranteed. This study aimed to elucidate the effect of proton pump inhibitors on the risk of pre-eclampsia, gestational diabetes mellitus, preterm birth, an Apgar score at 5\u00a0min below 7, and a child being small or large for its gestational age.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This Swedish population-based study included 1,089,514 live singleton deliveries between July 2006 and December 2016 in Sweden. Multiple logistic regression was used to model the outcomes as a function of the covariates. Results were presented as odds ratios with 95% confidence intervals.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In 1.4% of all pregnancies, the mother used proton pump inhibitors in the period from 3\u00a0months before the last menstrual period up to delivery. The use of proton pump inhibitors was associated with higher odds of pre-eclampsia (odds ratio\u2009=\u20091.19, 1.10\u20131.29), gestational diabetes mellitus (odds ratio\u2009=\u20091.29, 1.16\u20131.43), preterm birth (odds ratio\u2009=\u20091.23, 1.14\u20131.32), and small for gestational age (odds ratio\u2009=\u20091.27, 1.16\u20131.40) and lower odds of large for gestational age (odds ratio\u2009=\u20090.84, 0.77\u20130.91). No significant association was found with a low Apgar score 5\u00a0min after birth.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Proton pump inhibitor use was associated with a higher risk of pre-eclampsia, gestational diabetes, preterm birth, and being born small for gestational age.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12916-022-02673-x","type":"journal-article","created":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T13:03:51Z","timestamp":1671541431000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Population-based cohort study: proton pump inhibitor use during pregnancy in Sweden and the risk of maternal and neonatal adverse events"],"prefix":"10.1186","volume":"20","author":[{"given":"Esmee M.","family":"Breddels","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Simin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Fornes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Lilja Engstrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Engstrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Bruyndonckx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nele","family":"Brusselaers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,20]]},"reference":[{"issue":"7","key":"2673_CR1","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1023\/A:1015863018105","volume":"47","author":"S Nikfar","year":"2002","unstructured":"Nikfar S, Abdollahi M, Moretti ME, Magee LA, Koren G. Use of proton pump inhibitors during pregnancy and rates of major malformations: a meta-analysis. Dig Dis Sci. 2002;47(7):1526\u20139.","journal-title":"Dig Dis Sci"},{"issue":"4","key":"2673_CR2","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/apt.15610","volume":"51","author":"CM Li","year":"2020","unstructured":"Li CM, Zhernakova A, Engstrand L, Wijmenga C, Brusselaers N. Systematic review with meta-analysis: the risks of proton pump inhibitors during pregnancy. Aliment Pharmacol Ther. 2020;51(4):410\u201320.","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"2673_CR3","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s11096-015-0150-z","volume":"37","author":"HF Boardman","year":"2015","unstructured":"Boardman HF, Heeley G. The role of the pharmacist in the selection and use of over-the-counter proton-pump inhibitors. Int J Clin Pharm. 2015;37(5):709\u201316.","journal-title":"Int J Clin Pharm"},{"issue":"5","key":"2673_CR4","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1097\/00045391-200309000-00010","volume":"10","author":"J Cohen","year":"2003","unstructured":"Cohen J. Switching omeprazole in Sweden and the United States. Am J Ther. 2003;10(5):370\u20136.","journal-title":"Am J Ther"},{"issue":"10","key":"2673_CR5","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1111\/j.1365-2036.2012.05073.x","volume":"35","author":"AB Andersen","year":"2012","unstructured":"Andersen AB, Erichsen R, Farkas DK, Mehnert F, Ehrenstein V, Sorensen HT. Prenatal exposure to acid-suppressive drugs and the risk of childhood asthma: a population-based Danish cohort study. Aliment Pharmacol Ther. 2012;35(10):1190\u20138.","journal-title":"Aliment Pharmacol Ther"},{"issue":"suppl_1","key":"2673_CR6","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1093\/nutrit\/nuv039","volume":"73","author":"O Goulet","year":"2015","unstructured":"Goulet O. Potential role of the intestinal microbiota in programming health and disease. Nutr Rev. 2015;73(suppl_1):32\u201340.","journal-title":"Nutr Rev"},{"key":"2673_CR7","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3389\/fimmu.2014.00595","volume":"5","author":"MS Payne","year":"2014","unstructured":"Payne MS, Bayatibojakhi S. Exploring preterm birth as a polymicrobial disease: an overview of the uterine microbiome. Front Immunol. 2014;5:595.","journal-title":"Front Immunol"},{"issue":"6","key":"2673_CR8","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1097\/ANC.0000000000000218","volume":"15","author":"AL Dunlop","year":"2015","unstructured":"Dunlop AL, Mulle JG, Ferranti EP, Edwards S, Dunn AB, Corwin EJ. Maternal microbiome and pregnancy outcomes that impact infant health: a review. Adv Neonatal Care. 2015;15(6):377\u201385.","journal-title":"Adv Neonatal Care"},{"issue":"4","key":"2673_CR9","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00281-020-00817-w","volume":"42","author":"E Bayar","year":"2020","unstructured":"Bayar E, Bennett PR, Chan D, Sykes L, MacIntyre DA. The pregnancy microbiome and preterm birth. Semin Immunopathol. 2020;42(4):487\u201399.","journal-title":"Semin Immunopathol"},{"key":"2673_CR10","doi-asserted-by":"publisher","first-page":"101671","DOI":"10.1016\/j.bpg.2020.101671","volume":"44\u201345","author":"GM Fuhler","year":"2020","unstructured":"Fuhler GM. The immune system and microbiome in pregnancy. Best Pract Res Clin Gastroenterol. 2020;44\u201345:101671.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"5","key":"2673_CR11","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1136\/gutjnl-2015-310376","volume":"65","author":"F Imhann","year":"2016","unstructured":"Imhann F, Bonder MJ, Vila AV, Fu J, Mujagic Z, Vork L, et al. Proton pump inhibitors affect the gut microbiome. Gut. 2016;65(5):740\u20138.","journal-title":"Gut"},{"key":"2673_CR12","doi-asserted-by":"crossref","unstructured":"Brusselaers N, Pereira M, Alm J, Engstrand L, Lilja Engstrand H. Effect of proton pump inhibitors in infants with esophageal atresia on the gut microbiome: a pilot cohort Gut Pathogens. 2022:In press (acceptance pending)","DOI":"10.1186\/s13099-022-00518-9"},{"issue":"9","key":"2673_CR13","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1111\/j.1365-2036.2005.02654.x","volume":"22","author":"J Richter","year":"2005","unstructured":"Richter J. The management of heartburn in pregnancy. Aliment Pharmacol Ther. 2005;22(9):749\u201357.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"2673_CR14","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1053\/j.gastro.2006.04.048","volume":"131","author":"U Mahadevan","year":"2006","unstructured":"Mahadevan U, Kane S. American Gastroenterological Association Institute Medical Position Statement on the use of gastrointestinal medications in pregnancy. Gastroenterology. 2006;131(1):278\u201382.","journal-title":"Gastroenterology"},{"key":"2673_CR15","unstructured":"Omeprazole Pregnancy and Breastfeeding Warnings 2022 [cited 2022 October 2022]. Available from: https:\/\/www.drugs.com\/pregnancy\/omeprazole.html"},{"issue":"8","key":"2673_CR16","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1046\/j.1365-2036.1999.00578.x","volume":"13","author":"G Nielsen","year":"1999","unstructured":"Nielsen G, S\u00f8rensen H, Thulstrup A, Tage-Jensen U, Olesen C, Ekbom A. The safety of proton pump inhibitors in pregnancy. Aliment Pharmacol Ther. 1999;13(8):1085\u20139.","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"2673_CR17","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/j.1365-2036.2005.02306.x","volume":"21","author":"O Diav-Citrin","year":"2005","unstructured":"Diav-Citrin O, Arnon J, Shechtman S, Schaefer C, Van Tonningen M, Clementi M, et al. The safety of proton pump inhibitors in pregnancy: a multicentre prospective controlled study. Aliment Pharmacol Ther. 2005;21(3):269\u201375.","journal-title":"Aliment Pharmacol Ther"},{"issue":"22","key":"2673_CR18","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1056\/NEJMoa1002689","volume":"363","author":"B Pasternak","year":"2010","unstructured":"Pasternak B, Hviid A. Use of proton-pump inhibitors in early pregnancy and the risk of birth defects. N Engl J Med. 2010;363(22):2114\u201323.","journal-title":"N Engl J Med"},{"issue":"3","key":"2673_CR19","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s10620-011-1940-3","volume":"57","author":"I Matok","year":"2012","unstructured":"Matok I, Levy A, Wiznitzer A, Uziel E, Koren G, Gorodischer R. The safety of fetal exposure to proton-pump inhibitors during pregnancy. Dig Dis Sci. 2012;57(3):699\u2013705.","journal-title":"Dig Dis Sci"},{"issue":"5","key":"2673_CR20","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1161\/HYPERTENSIONAHA.118.12547","volume":"73","author":"R Hastie","year":"2019","unstructured":"Hastie R, Bergman L, Cluver CA, Wikman A, Hannan NJ, Walker SP, et al. Proton pump inhibitors and preeclampsia risk among 157 720 women: a Swedish population register\u2013based cohort study. Hypertension. 2019;73(5):1097\u2013103.","journal-title":"Hypertension"},{"key":"2673_CR21","doi-asserted-by":"crossref","unstructured":"Fornes R, Simin J, M.N. N, Cruz G, Crisosto N, Van Der Schaaf M et al. Pregnancy, perinatal and childhood outcomes in women with and without Polycystic Ovary Syndrome and metformin during pregnancy: a nationwide population-based study. Reprod Biol Endocrinol. 2022;In press","DOI":"10.1186\/s12958-022-00905-6"},{"key":"2673_CR22","doi-asserted-by":"crossref","unstructured":"Nguyen H, Fornes R, Kamau N, Danielsson H, Callens S, Fransson E et al. Antibiotic use during pregnancy and the risk of preterm birth: a population-based Swedish cohort study. J Antimicrob Chemother (JAC). 2022;In press","DOI":"10.1093\/jac\/dkac053"},{"key":"2673_CR23","unstructured":"K\u00e4ll\u00e9n BaK, Karin. The Swedish Medical Birth Register - a summary of content and quality. The Centre of Epdemiology - The National Board of Health and Welfare; 2003"},{"key":"2673_CR24","unstructured":"The Swedish Medical Birth Registry - Statistics Sweden 2021 [Available from: https:\/\/www.socialstyrelsen.se\/en\/statistics-and-data\/registers\/register-information\/the-swedish-medical-birth-register\/."},{"issue":"6","key":"2673_CR25","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1034\/j.1600-0412.2003.00172.x","volume":"82","author":"O Axelsson","year":"2003","unstructured":"Axelsson O. The Swedish medical birth register. Acta Obstet Gynecol Scand. 2003;82(6):491\u20132.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"7","key":"2673_CR26","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/pds.1294","volume":"16","author":"B Wettermark","year":"2007","unstructured":"Wettermark B, Hammar N, Fored CM, Leimanis A, Otterblad Olausson P, Bergman U, et al. The new Swedish Prescribed Drug Register\u2013opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf. 2007;16(7):726\u201335.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2673_CR27","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/1471-2458-11-450","volume":"11","author":"JF Ludvigsson","year":"2011","unstructured":"Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450.","journal-title":"BMC Public Health"},{"key":"2673_CR28","unstructured":"Socialstyrelsen. Kodningskvalitet i patientregistret - Ett nytt verktyg f\u00f6r att m\u00e4ta kvalitet. 2013"},{"issue":"11","key":"2673_CR29","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s10654-009-9350-y","volume":"24","author":"JF Ludvigsson","year":"2009","unstructured":"Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol. 2009;24(11):659\u201367.","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"2673_CR30","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12958-022-00905-6","volume":"20","author":"R Fornes","year":"2022","unstructured":"Fornes R, Simin J, Nguyen MH, Cruz G, Crisosto N, van der Schaaf M, et al. Pregnancy, perinatal and childhood outcomes in women with and without polycystic ovary syndrome and metformin during pregnancy: a nationwide population-based study. Reprod Biol Endocrinol: RB&E. 2022;20(1):30.","journal-title":"Reprod Biol Endocrinol: RB&E"},{"issue":"7","key":"2673_CR31","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/j.1651-2227.1996.tb14164.x","volume":"85","author":"K Marsal","year":"1996","unstructured":"Marsal K, Persson PH, Larsen T, Lilja H, Selbing A, Sultan B. Intrauterine growth curves based on ultrasonically estimated foetal weights. Acta Paediatr. 1996;85(7):843\u20138.","journal-title":"Acta Paediatr"},{"key":"2673_CR32","doi-asserted-by":"publisher","first-page":"217047","DOI":"10.1155\/2015\/217047","volume":"2015","author":"WY Lam","year":"2015","unstructured":"Lam WY, Fresco P. Medication adherence measures: an overview. Biomed Res Int. 2015;2015:217047.","journal-title":"Biomed Res Int"},{"key":"2673_CR33","doi-asserted-by":"crossref","unstructured":"Hosmer DW, Lemeshow S, Sturdivant RX, Hosmer DW, Jr. Applied logistic regression. New York, UNITED STATES: Wiley, Incorporated; 2013","DOI":"10.1002\/9781118548387"},{"key":"2673_CR34","unstructured":"Agresti A. Categorical data analysis. Third;3rd; ed. Hoboken, N.J: Wiley-Interscience; 2013"},{"key":"2673_CR35","unstructured":"Statistics Sweden. [January 2017]. Available from: http:\/\/www.socialstyrelsen.se\/barnochfamilj\/graviditet"},{"key":"2673_CR36","volume-title":"Applied linear statistical models","author":"J Neter","year":"1996","unstructured":"Neter J, Kutner MH, Nachtsheim CJ, Wasserman W. Applied linear statistical models. 4th ed. Chicago, Ill: Irwin; 1996.","edition":"4"},{"issue":"3","key":"2673_CR37","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1080\/09720502.2010.10700699","volume":"13","author":"H Midi","year":"2010","unstructured":"Midi H, Sarkar SK, Rana S. Collinearity diagnostics of binary logistic regression model. J Interdisc Math. 2010;13(3):253\u201367.","journal-title":"J Interdisc Math"},{"issue":"1","key":"2673_CR38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","volume":"73","author":"K-Y Liang","year":"1986","unstructured":"Liang K-Y, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73(1):13\u201322.","journal-title":"Biometrika"},{"key":"2673_CR39","unstructured":"R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2019"},{"key":"2673_CR40","unstructured":"Conway J, Eddelbuettel D, Nishiyama T, Prayaga SK, Tiffin N. RPostgreSQL: R Interface to the \u2018PostgreSQL\u2019 Database System. R Found Stat Comput. 2017. https:\/\/cran.r-project.org\/web\/packages\/RPostgreSQL\/RPostgreSQL.pdf."},{"key":"2673_CR41","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-2818-7","volume-title":"Vector generalized linear and additive models: with an implementation in R","author":"TW Yee","year":"2015","unstructured":"Yee TW. Vector generalized linear and additive models: with an implementation in R. New York, USA: Springer; 2015."},{"issue":"2","key":"2673_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v015.i02","volume":"15","author":"U Halekoh","year":"2006","unstructured":"Halekoh U, H\u00f8jsgaard S, Yan J. The R package geepack for generalized estimating equations. J Stat Softw. 2006;15(2):1\u201311.","journal-title":"J Stat Softw"},{"issue":"14","key":"2673_CR43","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1055\/s-0040-1713864","volume":"38","author":"NA Bello","year":"2021","unstructured":"Bello NA, Huang Y, Syeda SK, Wright JD, D\u2019Alton ME, Friedman AM. Receipt of proton-pump inhibitors during pregnancy and risk for preeclampsia. Am J Perinatol. 2021;38(14):1519\u201325.","journal-title":"Am J Perinatol"},{"issue":"9","key":"2673_CR44","doi-asserted-by":"publisher","first-page":"e2124339","DOI":"10.1001\/jamanetworkopen.2021.24339","volume":"4","author":"A Choi","year":"2021","unstructured":"Choi A, Noh Y, Park SH, Choe SA, Shin JY. Exploration of proton pump inhibitors use during pregnancy and preeclampsia. JAMA Netw Open. 2021;4(9):e2124339.","journal-title":"JAMA Netw Open"},{"issue":"9","key":"2673_CR45","first-page":"Cd011379","volume":"2015","author":"V Phupong","year":"2015","unstructured":"Phupong V, Hanprasertpong T. Interventions for heartburn in pregnancy. Cochrane Database Syst Rev. 2015;2015(9):Cd011379.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"2673_CR46","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1041-2972.2005.00003.x","volume":"17","author":"L Christopher","year":"2005","unstructured":"Christopher L. The role of proton pump inhibitors in the treatment of heartburn during pregnancy. J Am Acad Nurse Pract. 2005;17(1):4\u20138.","journal-title":"J Am Acad Nurse Pract"},{"issue":"2","key":"2673_CR47","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/apt.16407","volume":"54","author":"EM Salvo","year":"2021","unstructured":"Salvo EM, Ferko NC, Cash SB, Gonzalez A, Kahrilas PJ. Umbrella review of 42 systematic reviews with meta-analyses: the safety of proton pump inhibitors. Aliment Pharmacol Ther. 2021;54(2):129\u201343.","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"2673_CR48","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1080\/19490976.2017.1284732","volume":"8","author":"F Imhann","year":"2017","unstructured":"Imhann F, Vich Vila A, Bonder MJ, Lopez Manosalva AG, Koonen DPY, Fu J, et al. The influence of proton pump inhibitors and other commonly used medication on the gut microbiota. Gut Microbes. 2017;8(4):351\u20138.","journal-title":"Gut Microbes"},{"issue":"9461","key":"2673_CR49","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S0140-6736(05)17987-2","volume":"365","author":"B Sibai","year":"2005","unstructured":"Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. The Lancet. 2005;365(9461):785\u201399.","journal-title":"The Lancet"},{"key":"2673_CR50","doi-asserted-by":"publisher","first-page":"S88","DOI":"10.2337\/diacare.27.2007.S88","volume":"27","author":"American Diabetes Association","year":"2004","unstructured":"American Diabetes Association. Gestational diabetes mellitus. Diabetes Care. 2004;27:S88.","journal-title":"Diabetes Care"},{"issue":"1","key":"2673_CR51","first-page":"33","volume":"34","author":"P Chatelain","year":"2000","unstructured":"Chatelain P. Children born with intrauterine growth retardation (IUGR) or small for gestational age (SGA): long term growth and metabolic consequences. Endocr Regul. 2000;34(1):33\u20136.","journal-title":"Endocr Regul"},{"issue":"1","key":"2673_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7525-10-146","volume":"10","author":"LK Lund","year":"2012","unstructured":"Lund LK, Vik T, Lydersen S, L\u00f8haugen GC, Skranes J, Brubakk A-M, et al. Mental health, quality of life and social relations in young adults born with low birth weight. Health Qual Life Outcomes. 2012;10(1):1\u201310.","journal-title":"Health Qual Life Outcomes"},{"issue":"16","key":"2673_CR53","first-page":"276","volume":"115","author":"J Stubert","year":"2018","unstructured":"Stubert J, Reister F, Hartmann S, Janni W. The risks associated with obesity in pregnancy. Deutsches Arzteblatt Int. 2018;115(16):276\u201383.","journal-title":"Deutsches Arzteblatt Int"},{"key":"2673_CR54","doi-asserted-by":"publisher","first-page":"j1","DOI":"10.1136\/bmj.j1","volume":"356","author":"PM Catalano","year":"2017","unstructured":"Catalano PM, Shankar K. Obesity and pregnancy: mechanisms of short term and long term adverse consequences for mother and child. BMJ. 2017;356:j1.","journal-title":"BMJ"},{"issue":"2","key":"2673_CR55","doi-asserted-by":"publisher","first-page":"164.e1","DOI":"10.1016\/j.ajog.2009.09.029","volume":"202","author":"YH Chen","year":"2010","unstructured":"Chen YH, Lin HC, Lou HY. Increased risk of low birthweight, infants small for gestational age, and preterm delivery for women with peptic ulcer. Am J Obstet Gynecol. 2010;202(2):164.e1-8.","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"2673_CR56","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1111\/j.1471-0528.1998.tb10234.x","volume":"105","author":"LV Wilton","year":"1998","unstructured":"Wilton LV, Pearce GL, Martin RM, Mackay FJ, Mann RD. The outcomes of pregnancy in women exposed to newly marketed drugs in general practice in England. Br J Obstet Gynaecol. 1998;105(8):882\u20139.","journal-title":"Br J Obstet Gynaecol"},{"issue":"5","key":"2673_CR57","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1161\/HYPERTENSIONAHA.118.12547","volume":"73","author":"R Hastie","year":"2019","unstructured":"Hastie R, Bergman L, Cluver CA, Wikman A, Hannan NJ, Walker SP, et al. Proton pump inhibitors and preeclampsia risk among 157 720 women. Hypertension. 2019;73(5):1097\u2013103.","journal-title":"Hypertension"},{"issue":"5","key":"2673_CR58","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1093\/oxfordjournals.aje.a010036","volume":"150","author":"A Ruigomez","year":"1999","unstructured":"Ruigomez A, Garcia Rodriguez LA, Cattaruzzi C, Troncon MG, Agostinis L, Wallander MA, et al. Use of cimetidine, omeprazole, and ranitidine in pregnant women and pregnancy outcomes. Am J Epidemiol. 1999;150(5):476\u201381.","journal-title":"Am J Epidemiol"},{"key":"2673_CR59","doi-asserted-by":"publisher","first-page":"175628481877794","DOI":"10.1177\/1756284818777943","volume":"11","author":"OO Halfdanarson","year":"2018","unstructured":"Halfdanarson OO, Pottegard A, Bjornsson ES, Lund SH, Ogmundsdottir MH, Steingrimsson E, et al. Proton-pump inhibitors among adults: a nationwide drug-utilization study. Therap Adv Gastroenterol. 2018;11:1756284818777943.","journal-title":"Therap Adv Gastroenterol"},{"issue":"11","key":"2673_CR60","doi-asserted-by":"publisher","first-page":"e040473","DOI":"10.1136\/bmjopen-2020-040473","volume":"10","author":"Y Liu","year":"2020","unstructured":"Liu Y, Zhu X, Li R, Zhang J, Zhang F. Proton pump inhibitor utilisation and potentially inappropriate prescribing analysis: insights from a single-centred retrospective study. BMJ Open. 2020;10(11):e040473.","journal-title":"BMJ Open"},{"issue":"5","key":"2673_CR61","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1177\/1756283X16650156","volume":"9","author":"A Pottegard","year":"2016","unstructured":"Pottegard A, Broe A, Hallas J, de Muckadell OB, Lassen AT, Lodrup AB. Use of proton-pump inhibitors among adults: a Danish nationwide drug utilization study. Ther Adv Gastroenterol. 2016;9(5):671\u20138.","journal-title":"Ther Adv Gastroenterol"},{"issue":"2","key":"2673_CR62","doi-asserted-by":"publisher","first-page":"e56060","DOI":"10.1371\/journal.pone.0056060","volume":"8","author":"SR Rotman","year":"2013","unstructured":"Rotman SR, Bishop TF. Proton pump inhibitor use in the U.S. ambulatory setting, 2002-2009. PloS one. 2013;8(2):e56060.","journal-title":"PloS one."},{"issue":"3","key":"2673_CR63","doi-asserted-by":"publisher","first-page":"180","DOI":"10.4292\/wjgpt.v8.i3.180","volume":"8","author":"C Tosetti","year":"2017","unstructured":"Tosetti C, Nanni I. Use of proton pump inhibitors in general practice. World J Gastrointest Pharmacol Ther. 2017;8(3):180\u20135.","journal-title":"World J Gastrointest Pharmacol Ther"},{"issue":"5","key":"2673_CR64","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1097\/00045391-200309000-00010","volume":"10","author":"J Cohen","year":"2003","unstructured":"Cohen J. Switching omeprazole in Sweden and the United States. Am J Ther. 2003;10(5):370\u20136.","journal-title":"Am J Ther"},{"key":"2673_CR65","unstructured":"Fertility Statistics - Eurostat statistics explained [cited 2022. Available from: https:\/\/ec.europa.eu\/eurostat\/statistics-explained\/index.php?title=Fertility_statistics#The_birth_rate_in_the_EU_decreased_at_a_slower_pace_between_2000_and_2020_than_previously"},{"key":"2673_CR66","first-page":"CD011969","volume":"3","author":"TA Boghossian","year":"2017","unstructured":"Boghossian TA, Rashid FJ, Thompson W, Welch V, Moayyedi P, Rojas-Fernandez C, et al. Deprescribing versus continuation of chronic proton pump inhibitor use in adults. Cochrane Database Syst Rev. 2017;3:CD011969.","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"2673_CR67","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11894-018-0632-y","volume":"20","author":"J Kim","year":"2018","unstructured":"Kim J, Blackett JW, Jodorkovsky D. Strategies for effective discontinuation of proton pump inhibitors. Curr Gastroenterol Rep. 2018;20(6):27.","journal-title":"Curr Gastroenterol Rep"},{"issue":"4","key":"2673_CR68","doi-asserted-by":"publisher","first-page":"388 e1","DOI":"10.1016\/j.ajog.2018.07.019","volume":"219","author":"CA Cluver","year":"2018","unstructured":"Cluver CA, Hannan NJ, van Papendorp E, Hiscock R, Beard S, Mol BW, et al. Esomeprazole to treat women with preterm preeclampsia: a randomized placebo controlled trial. Am J Obstet Gynecol. 2018;219(4):388 e1-e17.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"2673_CR69","doi-asserted-by":"publisher","first-page":"e000221","DOI":"10.1136\/bmjdrc-2016-000221","volume":"4","author":"HE Fadl","year":"2016","unstructured":"Fadl HE, Simmons D. Trends in diabetes in pregnancy in Sweden 1998\u20132012. BMJ Open Diabetes Res Care. 2016;4(1):e000221.","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2673_CR70","doi-asserted-by":"crossref","unstructured":"Berkowitz GS, Blackmore-Prince C, Lapinski RH, Savitz DA. Risk factors for preterm birth subtypes. Epidemiology. 1998:9(3):279\u201385.","DOI":"10.1097\/00001648-199805000-00011"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-022-02673-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-022-02673-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-022-02673-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T03:12:54Z","timestamp":1671851574000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-022-02673-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,20]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2673"],"URL":"https:\/\/doi.org\/10.1186\/s12916-022-02673-x","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,20]]},"assertion":[{"value":"12 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approved by the Regional Ethics Committee of Stockholm (2017\/2423\u201331).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Waived because of registry-based nature.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"492"}}